Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Precision Diagnostics: Moving Towards Protein Biomarker Signatures Of Clinical Utility In Cancer.

Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer.

Carl A K Borrebaeck1

  • 1Department of Immunotechnology, CREATE Health Translational Cancer Center, Medicon Village (Bldg 406), Lund University, 223 81 Lund, Sweden.

Nature Reviews. Cancer
|February 4, 2017

Related Experiment Videos

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

621
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

1.1K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.3K

View abstract on PubMed

Summary
This summary is machine-generated.

Precision diagnostics using blood-based protein biomarker signatures offer improved cancer detection. Multiplex signatures in serum promise more accurate and effective early cancer management strategies.

Area of Science:

  • Biomedical Science
  • Proteomics
  • Cancer Diagnostics

Background:

  • Early cancer detection improves patient outcomes through increased resectability and treatment efficacy.
  • Serum proteomic analysis offers a rich source of diagnostic information.
  • Current diagnostic approaches require enhancement for greater precision.

Purpose of the Study:

  • To review the progress in identifying protein biomarker signatures for clinical utility in cancer diagnostics.
  • To highlight the shift from single biomarkers to multiplex signatures for enhanced diagnostic accuracy.
  • To discuss the application of blood-based proteomics in precision oncology.

Main Methods:

  • Literature review of advancements in affinity proteomics.
  • Analysis of strategies for developing multiplex protein biomarker signatures.

Related Experiment Videos

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

621
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

1.1K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.3K
  • Focus on blood-based (serum) proteomic data.

    • Main Results:

    • Protein biomarker signatures show potential for increased diagnostic accuracy compared to single markers.
    • Multiplex signatures can provide actionable information for precise cancer management.
    • Progress is being made in translating proteomic discoveries into clinical applications.

    Conclusions:

    • Multiplex protein biomarker signatures in serum represent a significant advancement in precision diagnostics.
    • Blood-based proteomics is crucial for developing evidence-based cancer management options.
    • The future of cancer diagnostics lies in integrated, multi-analyte approaches.